Join to access to all OVN content. Join for Free
How to create HIGH performing MSLs, teams and MSL leaders
field medical development evolving role of MSLs executive coaching soft skills for MSLs high-performing MSL teams

How to create HIGH performing MSLs, teams and MSL leaders


Share This Article


Summary

In this episode, Mike Penkethman delves into field medical development and the evolving role of MSLs. He emphasizes the importance of executive coaching, soft skills, and adapting to pandemic-driven changes. Mike provides insights into the attributes of high-performing MSLs, especially in virtual settings, and discusses the evaluation of MSL teams. He highlights strategies for team development, goal setting, and the significance of networking and centers of influence. The conversation also covers practical advice on verbalizing and documenting goals, honing soft skills, and crafting a compelling CV for aspiring MSLs. The episode concludes with reflective closing remarks and gratitude.

Check out my latest podcast with Mike Penkethman, Career Coach and President of the Pilotage Group. We discuss how to create high-performing MSLs, teams, and MSL leaders.

We discuss:

 What are the key attributes of high performing MSL
 What MSL interactions will look like in the future
 What do MSL Leaders look for in MSLs
 What is the most successful approach to KOL interactions
 What value and resources can (and should) MSLs bring to their KOLs

Click for Source
field medical development, evolving role of MSLs, executive coaching, soft skills for MSLs, high-performing MSL teams

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Article
Clinical Educator Oncology Program Improves Adherence by 29%​
Partner Avatar iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%​

Article
New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures
OVN Avatar Forbes Books Press Release Official

New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures

Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Explore OVN